index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

87

 

NOTICES

152

 

 

MOTS CLES

Atopic dermatitis CSK tyrosine-protein kinase Auto-immune hepatitis Ustekinumab Pharmacoepidemiology Ankylosing Placebo Alitretinoin Graft-versus-host disease Bacterial Aging ASDAS Pharmaco-Épidémiologie Glucocorticoids Anti-TNF Epidemiology Anxiété Immunotherapy Antimicrobial Stewardship Stability Pregnancy Vigibase® Cardiomyopathy Autoimmunity Adalimumab COVID-19 Auto-Diagnostic Méta-Analyse Biomarkers Intensive care Immune-related adverse events Biologics BTK protein Dermatology Angiotensin-converting enzyme inhibitors Antimicrobials Sipuleucel-T Angiotensin receptor blockers Albinism Autoimmune diseases Anti-Bacterial Agents Endocrine toxicity Drug survival Antibiotic resistance Etanercept Infliximab Biomédicaments Arrhythmia Primary adrenal insufficiency Cardiotoxicity Cardio-oncology Antimicrobiens Calcium channel blockers ArtThese Anti-HCV Direct Acting Antivirals DAA Pharmacovigilance Ethics Sacroiliitis Psoriasis Burden Biosimilar Pharmaceuticals Abus d'antibiotiques Treatment Addiction Management Drug reaction Prostate cancer Meta-Analysis Adverse side effects Amyloidosis Apremilast Atrial fibrillation Spondyloarthritis Beta-lactam antibiotics Azathioprine Biologic drug Biological Therapy Ankylosing spondylitis Biological therapy Quality of life Arthritis Apre-milast Axial spondyloarthritis CTLA-4 Alcohol Antimicrobial resistance Psoriatic arthritis Adolescent Anxiety Antibiotics Access to care Cancer Acute Myeloid Leukaemia AML Bacterial rhinosinusitis Biologic Biologic therapy Antibiotic misuse Immune checkpoint inhibitors Anticancer drugs Accelerometer

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS